Effect of M-Health on secondary prevention of coronary artery disease patients
- Conditions
- Coronary Artery disease.125.0125.1
- Registration Number
- IRCT20221016056204N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1544
History of CAD defined as history of myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, coronary angiography confirming stenosis>50% in at least one of the major epicardial coronary arteries or their main branches.
Having at least one uncontrolled risk factor including: uncontrolled hypertension, uncontrolled dyslipidemia and current cigarette smoking for =12 months.
Aged between 25 to 75 years
Inclination to staying in study for two years
Having and ability of using smart phone by the participant or one of his/her trustworthy relatives who lives near him/her
Willing to control the risk factors using App
Provides informed consent to participate in the study
Mental retardation
Individuals with prohibitive morbidity that requires close face-to-face monitoring.
End stage chronic disease such as: hepatic and/or renal failure, heart failure, active cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Smoking Cessation. Timepoint: Three months post-randomization. Method of measurement: Self-report for quitting smoking.;Blood pressure control to less than 130/80 mm Hg. Timepoint: Three months post-randomization. Method of measurement: Sphygmomanometer/Blood pressure measurement by the physician in the clinic.;Dyslipidemia control with the target of low-density lipoprotein cholesterol (LDL-C) less than 55 mg/dL. Timepoint: Three months post-randomization. Method of measurement: Lab test to measure low-density lipoprotein cholesterol.
- Secondary Outcome Measures
Name Time Method